Travere Therapeutics(TVTX) - 2025 Q4 - Earnings Call Transcript

Travere Therapeutics (NasdaqGM:TVTX) Q4 2025 Earnings call February 19, 2026 04:30 PM ET Company ParticipantsBill Rote - Chief Research OfficerChris Cline - CFOEric Dube - President and CEOGavin Clark-Gartner - Managing Director of Biotechnology Equity ResearchJason Zemansky - Managing DirectorJula Inrig - Chief Medical OfficerNivi Nehra - VP of Corporate Communications and Investor RelationsPeter Heerma - Chief Commercial OfficerConference Call ParticipantsAlex Thompson - Managing Director and Senior Equit ...